Skip to content
Clinical Research Made Simple

Clinical Research Made Simple

Trusted Resource for Clinical Trials, Protocols & Progress

Tag: ASEAN clinical trial approval

Ethics Committee Structures Across ASEAN Countries: Navigating Regional Variations

Posted on May 6, 2025 digi By digi

Ethics Committee Structures Across ASEAN Countries: Navigating Regional Variations Understanding Ethics Committee Frameworks in ASEAN: A Guide for Clinical Trial Professionals In clinical research, ethics committees play a critical role in safeguarding participant rights, safety, and well-being. Across the ASEAN region, where multi-country trials are increasing in frequency, understanding the structural and procedural variations among…

Read More “Ethics Committee Structures Across ASEAN Countries: Navigating Regional Variations” »

ASEAN Guidelines, Regulatory Guidelines

Quick Guide

  • Clinical Trial Phases
    • Preclinical Studies
    • Phase 0 (Microdosing Studies)
    • Phase 1 (Safety and Dosage)
    • Phase 2 (Efficacy and Side Effects)
    • Phase 3 (Confirmation and Monitoring)
    • Phase 4 (Post-Marketing Surveillance)
  • Regulatory Guidelines
    • U.S. FDA Regulations
    • CDSCO (India) Guidelines
    • EMA (European Medicines Agency) Guidelines
    • PMDA (Japan) Guidelines
    • MHRA (UK) Guidelines
    • TGA (Australia) Guidelines
    • Health Canada Guidelines
    • WHO Guidelines
    • ICH Guidelines
    • ASEAN Guidelines
  • Clinical Trial Design and Protocol Development
    • Randomized Controlled Trials (RCTs)
    • Adaptive Trial Designs
    • Crossover Trials
    • Parallel Group Designs
    • Factorial Designs
    • Cluster Randomized Trials
    • Single-Arm Trials
    • Open-Label Studies
    • Blinded Studies (Single, Double, Triple)
    • Non-Inferiority and Equivalence Trials
    • Randomization Techniques in Crossover Trials
  • Good Clinical Practice (GCP) and Compliance
    • GCP Training Programs
    • ICH-GCP Compliance
    • GCP Violations and Audit Responses
    • Monitoring Plans
    • Investigator Responsibilities
    • Sponsor Responsibilities
    • Ethics Committee Roles

Menu

Recent Posts

  • The Role of Pharmacometrics in Dose Prediction for Phase 1
  • Data Integrity and Traceability in Long-Duration Phase 3 Studies: Building Trust Through Robust Data Management
  • Incorporating PROs and QoL Data in Phase 4 Clinical Trials
  • Evaluating Drug Efficacy Using Parallel Methodology – Clinical Trial Design and Protocol Development
  • Phase 1 Studies for Inhaled Therapies: PK, PD, and Device Considerations

Copyright © 2025 Clinical Research Made Simple.

Powered by PressBook WordPress theme